Mons, Martijn R. http://orcid.org/0000-0002-4682-5484
Edelbroek, Caro
Zuidema, Xander
Bürger, Katja
Elzinga, Lars
de Vries, Jessica
van Kuijk, Sander
Joosten, Elbert A.
Kallewaard, Jan-Willem
Funding for this research was provided by:
Abbott Laboratories
Article History
Received: 25 February 2022
Accepted: 5 August 2022
First Online: 5 September 2022
Declarations
:
: This study will be conducted according to the principles of the Declaration of Helsinki and in accordance with the WMO. This study protocol has been approved by the (CMO) Arnhem-Nijmegen under NL-number NL 75451.091.20 and has been registered at ClinicalTrials.gov under NCT05421273 and the Netherlands Trial Register under NL9194.
: No personal information will be published as a result of this trial.
: JWK is part of the advisory board for Abbot Laboratories, Boston Scientific, Saluda Medical, Medtronic and Nevro Corporation. XZ is part of the advisory board of Medtronic. All other authors declare no competing interests.